Decreased hemoglobin after initial treatment is associated with treatment resistance in Kawasaki disease in Kobayashi risk stratification

被引:6
作者
Atsumi, Yukari [1 ,6 ]
Sakakibara, Hiroshi [1 ]
Morikawa, Yoshihiko [2 ]
Miyata, Koichi [3 ]
Yamagishi, Hiroyuki [4 ]
Misawa, Masahiro [5 ]
Miura, Masaru [2 ,3 ]
机构
[1] Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Tokyo, Japan
[2] Tokyo Metropolitan Childrens Med Ctr, Clin Res Support Ctr, Tokyo, Japan
[3] Tokyo Metropolitan Childrens Med Ctr, Dept Cardiol, Tokyo, Japan
[4] Keio Univ, Dept Pediat, Sch Med, Tokyo, Japan
[5] Tokyo Metropolitan Bokutoh Hosp, Dept Pediat, Tokyo, Japan
[6] Natl Ctr Global Hlth & Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan
关键词
Anemia; Inflammation; Hepcidin; Kawasaki disease; INTRAVENOUS GAMMA-GLOBULIN; INFLAMMATION; IRON;
D O I
10.1007/s12519-020-00385-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Although Kawasaki disease (KD) is known to cause anemia, the relationship between its prognosis and hemoglobin level is less well known. Methods We herein performed a secondary analysis of data from a previous study (Post-RAISE). Children aged 6 months to 2 years at the time of KD diagnosis were enrolled. Decreased hemoglobin was defined as a decrease > 10% on post-treatment day 2 compared with the level prior to the initial therapy. Results Of 1253 KD cases, treatment resistance was observed in 209 (17%) and was significantly more frequent in the decreased hemoglobin group (37/167 vs. 172/1086,P = 0.041). Multivariable logistic regression analysis revealed that decreased hemoglobin was associated with resistance to the initial treatment (odds ratio 1.53; 95% confidence interval 1.00-2.33;P = 0.048). Conclusions Decreased hemoglobin was significantly associated with resistance to initial treatment in patients with KD.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 17 条
  • [1] Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
    Berard, Roberta
    Whittemore, Blair
    Scuccimarri, Rosie
    [J]. PEDIATRIC RHEUMATOLOGY, 2012, 10
  • [2] Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention A Systematic Review and Meta-analysis
    Chen, Shaojie
    Dong, Ying
    Kiuchi, Marcio Galindo
    Wang, Jiazhi
    Li, Ruotian
    Ling, Zhiyu
    Zhou, Tingquan
    Wang, Zhenglong
    Martinek, Martin
    Purerfeliner, Helmut
    Liu, Shaowen
    Krucoff, Mitchell W.
    [J]. JAMA PEDIATRICS, 2016, 170 (12) : 1156 - 1163
  • [3] FURUSHO K, 1984, LANCET, V2, P1055
  • [4] TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease
    Hu, Peng
    Jiang, Guang Mei
    Wu, Yue
    Huang, Bao Yu
    Liu, Si Yan
    Zhang, Dong Dong
    Xu, Yao
    Wu, Yang Fang
    Xia, Xun
    Wei, Wei
    Hu, Bo
    [J]. CLINICA CHIMICA ACTA, 2017, 471 : 76 - 80
  • [5] Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients
    Huang, Ying-Hsien
    Kuo, Ho-Chang
    Huang, Fu-Chen
    Yu, Hong-Ren
    Hsieh, Kai-Sheng
    Yang, Ya-Ling
    Sheen, Jiunn-Ming
    Li, Sung-Chou
    Kuo, Hsing-Chun
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [6] Kawasaki T, 1967, Arerugi, V16, P178
  • [7] A New Z Score Curve of the Coronary Arterial Internal Diameter Using the Lambda-Mu-Sigma Method in a Pediatric Population
    Kobayashi, Tohru
    Fuse, Shigeto
    Sakamoto, Naoko
    Mikami, Masashi
    Ogawa, Shunichi
    Hamaoka, Kenji
    Arakaki, Yoshio
    Nakamura, Tsuneyuki
    Nagasawa, Hiroyuki
    Kato, Taichi
    Jibiki, Toshiaki
    Iwashima, Satoru
    Yamakawa, Masaru
    Ohkubo, Takashi
    Shimoyama, Shinya
    Aso, Kentaro
    Sato, Seiichi
    Saji, Tsutomu
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2016, 29 (08) : 794 - +
  • [8] Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial
    Kobayashi, Tohru
    Saji, Tsutomu
    Otani, Tetsuya
    Takeuchi, Kazuo
    Nakamura, Tetsuya
    Arakawa, Hirokazu
    Kato, Taichi
    Hara, Toshiro
    Hamaoka, Kenji
    Ogawa, Shunichi
    Miura, Masaru
    Nomura, Yuichi
    Fuse, Shigeto
    Ichida, Fukiko
    Seki, Mitsuru
    Fukazawa, Ryuji
    Ogawa, Chitose
    Furuno, Kenji
    Tokunaga, Hirohide
    Takatsuki, Shinichi
    Hara, Shinya
    Morikawa, Akihiro
    [J]. LANCET, 2012, 379 (9826) : 1613 - 1620
  • [9] High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease
    Kuo, Ho-Chang
    Lo, Mao-Hung
    Hsieh, Kai-Sheng
    Guo, Mindy Ming-Huey
    Huang, Ying-Hsien
    [J]. PLOS ONE, 2015, 10 (12):
  • [10] Inflammation-Induced Hepcidin is Associated with the Development of Anemia and Coronary Artery Lesions in Kawasaki Disease
    Kuo, Ho-Chang
    Yang, Ya-Ling
    Chuang, Jiin-Haur
    Tiao, Mao-Meng
    Yu, Hong-Ren
    Huang, Li-Tung
    Yang, Kuender D.
    Chang, Wei-Chiao
    Lee, Chiu-Ping
    Huang, Ying-Hsien
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (04) : 746 - 752